In this c.$800m1 segment, we are the market leader.
Our AQUACEL® Ag dressings are the #1 anti-microbial dressings today2, combining the infection-fighting power of ionic silver with the unique capabilities of Hydrofiber® Technology.
1. SmartTRAK estimate
2. Data on file, Convatec Inc.
This segment is worth
c. $1.6bn.
We have a variety of foam dressings and at the beginning of 2023 launched ConvaFoam in the US.
;
This segment is worth
c. $400m.
We have the Avelle product.
This segment is worth
c. $1.8bn.
Following the acquisition of Triad Life Sciences in 2022 Convatec entered the Advanced Wound Biologics3 segment.
Our Innovamatrix products are used for the treatment of hard to heal wounds.
;
Our AQUACEL® Dressings launched 20 years ago with a breakthrough technology — Hydrofiber®. Since then, we’ve never stopped innovating. Today, the AQUACEL® family includes a wide range of wound dressings — including AQUACEL® Ag Extra™, AQUACEL® Ag+ Extra™, AQUACEL® Surgical and AQUACEL® Ag Burn.